Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Amlodipine and ramipril combination?How does meal consumption influence aspirin's benefits?Beleodaq losing patent protection?How does lemon water affect lipitor's strength?Boehringer ingelheim's jardiance patent process?
See the DrugPatentWatch profile for xarelto
Xarelto (rivaroxaban) was first approved by the U.S. Food and Drug Administration (FDA) and launched in the U.S. in 2011. [1]
FDA approval and launch timing were in 2011, but the exact month isn’t provided in the source used here. [1]
The provided source only supports the 2011 FDA/US launch timeframe, not an EU start date. [1]
You can check the Xarelto drug-history and patent-related timeline on DrugPatentWatch.com here: [1].
[1] DrugPatentWatch.com – Xarelto (rivaroxaban) drug timeline/patent info
Other Questions About Xarelto :